Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
eNq1mE1z2jAQhu/8Co8PvWFjPgK0NpmWJi0zyZQSmHZ6YYS9BFEjOfoA0l9fGZMGOnLTCHS0Zb+70q4evaPwcrtKnTUwjimJ3MCruQ6QmCaY3EfuZHxd7biXvUq4RGt08Fnbq3lB3XXiFHEeufmoNwNEuPf99uYjqP+Bub2KE9LZEmJx9J0UOPU+I764RVn+jROuKU6cFYgFTSI3k2L31gm5YCqL3oaynzxDMYT+/s3h6HLaPHwf+rnYf6hKDuwGkXutKBAjzVgyBkT0kYB7yh5L8m0YaWM+Ak4li2GIxGLI6BonkGhDzFHKwSjIfJPcAVunIPIgWnF/Ga+4kThaou0IHgb6pN+r0b7YimqtGrRbzaAb1Jv17kXbKBQ7WCp9FdQk/HgaNFrddqPmA1HKakQVz7A4Q8oESi2VBfP+cWdZisPg4cXyJ5hnKXr0ljwzXSrEkBoGpva/vYnkMxgzRaRUrdlf+kSmqf/KrCd7XljKOMdRn0oiSrBxPTJdiD4lArblFTUjndjuexEDP5/sL0r0lB/KWYpjU6Yp6kjgYjIalCPtrDT4gDhMmD0cfMMkoRt+fswcltVS9tmOlFrRjCXBtN7tXAStlvEu+qF6qOSMuZKMZuArAGF+ClcGZE5PJYpqS73UU1Oerx93VofGKIUSs1M1pItqxCdvZq3V7W2jYkAr+ulqbNofXyWwx7vdo1YaJ9Gfypqh1wbPVTe+lHixb6Ns2qi1Ot1G8w1aZe+eXHRk6JgLUSuGWTI9ZBZCZPyt7282G2+BeJUjtZ7enP3jFLjUzv0c81fIfS6nPVNvxQMUnqjAraXUZ8U5+ro6mu7cl1zCqc53///eYWtjCCbhhFoUkLeG4sHV+en+bHutpT08Yoy9MDuLigSmxJZzkjOt4mnniaoruWYKEF/mc1xyyVLal6FfXPD0KqGfX+70Kr8BQxYClA==
EyybbStWmsGTGNx2
Listen
